Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Ilaprazole, Clarithromycin, and Amoxicillin
NCT02998437Phase 1Completed
- Sponsor
- Il-Yang Pharmaceutical
- Start
- Dec 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ilaprazole in Helicobacter pylori infection (3 arms), sponsored by Il-Yang Pharmaceutical. Primary endpoints: Ilaprazole Area Under the plasma concentration-time Curve at the last observed time point at 48 hours, Ilaprazole Maximum Serum Concentration at 48 hours and 2 more. Started Dec 2016; status: completed.
02
Drugs
ilaprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02998437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02998437.